Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Active Biotech cancer news

    Active Biotech AB (SSE:ACTI), Lund, Sweden Business: Cancer Active Biotech will reduce its headcount by 37 (66%) to 19 employees after announcing in April that it would discontinue development of tasquinimod. The Phase …

    Published on 7/27/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a ruling and extended an …

    Published on 7/27/2015
  • AstraZeneca, Biogen, Teva pharmaceuticals news

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Pharmaceuticals The companies will pay $55.5 …

    Published on 7/27/2015
  • Emergent BioSolutions, U.S. Department of Health and Human Services infectious news

    Emergent BioSolutions Inc. (NYSE:EBS), Rockville, Md. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious HHSs Biomedical Advanced Research and Development Authority (BARDA) awarded …

    Published on 7/27/2015
  • Allergan, Eli Lilly cancer news

    Allergan plc (NYSE:AGN), Dublin, Ireland Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Cancer The U.K. Court of Appeal ruled that Allergans pemetrexed salt formulations would indirectly infringe an Alimta …

    Published on 7/20/2015
  • Sanofi pharmaceuticals news

    Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Pharmaceuticals Sanofi will reorganize into five global business units. The realignment is Sanofis first major move since Olivier Brandicourt took over as CEO in …

    Published on 7/20/2015
  • TxCell autoimmune news

    TxCell S.A. (Euronext:TXCL), Valbonne, France Business: Autoimmune TxCell halted manufacturing at its pilot facility in Besancon, France, to ensure GMP compliance for eliminating the risk of microbial contamination in …

    Published on 7/20/2015
  • Amgen, AbbVie autoimmune news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. AbbVie Inc. (NYSE:ABBV), Chicago, Ill. Business: Autoimmune Amgen filed two inter partes review (IPR) petitions with the U.S. Patent and Trademark Office challenging …

    Published on 7/13/2015
  • Celladon cardiovascular news

    Celladon Corp. (NASDAQ:CLDN), San Diego, Calif. Business: Cardiovascular Celladon will discontinue R&D and will cut the remainder of its R&D staff, or about 50% of its remaining 17 employees, after its board unanimously…

    Published on 7/13/2015
  • Chugai pharmaceuticals news

    Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Business: Pharmaceuticals Chugai is integrating and reorganizing its subsidiaries in Europe, China and Taiwan to streamline operations. In Europe, the business …

    Published on 7/13/2015
  • Entasis Therapeutics, AstraZeneca infectious news

    Entasis Therapeutics Inc., Waltham, Mass. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Infectious AstraZeneca completed the spinout of its early stage antibiotics programs into stand-alone company …

    Published on 7/13/2015
  • Hospira, Medicines Co. cardiovascular news

    Hospira Inc. (NYSE:HSP), Lake Forest, Ill. The Medicines Co. (NASDAQ:MDCO), Parsippany, N.J. Business: Cardiovascular The U.S. Court of Appeals for the Federal Circuit ruled that two patents covering Angiomax …

    Published on 7/13/2015
  • Transgene cancer, infectious news

    Transgene S.A. (Euronext:TNG), Illkirch, France Business: Cancer, Infectious Transgene plans to reduce its headcount by 120 (42%) to about 163 and focus on clinical development and translational R&D in oncology and …

    Published on 7/13/2015
  • Allergan ophthalmic news

    Allergan plc (NYSE:AGN), Dublin, Ireland Business: Ophthalmic Allergan filed suit against Ferrum Ferro Capital in the U.S. District Court for the Central District of California alleging the hedge fund attempted to …

    Published on 6/29/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars The Sandoz unit of Novartis requested that the U.S. Court of Appeals for the Federal Circuit (…

    Published on 6/29/2015
  • Bristol-Myers infectious news

    Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Infectious Bristol-Myers said it will discontinue drug discovery in virology and cut about 100 jobs as part of an ongoing R&D reorganization announced in …

    Published on 6/29/2015
  • Medivir neurology news

    Medivir AB (SSE:MVIR B), Huddinge, Sweden Business: Neurology Medivir said it will exit the neuropathic pain therapeutic area following adverse findings in non-clinical safety studies of MIV-247. Medivir has …

    Published on 6/29/2015
  • OraSure, U.S. Department of Health and Human Services diagnostic news

    OraSure Technologies Inc. (NASDAQ:OSUR), Bethlehem, Pa. U.S. Department of Health and Human Services, Washington, D.C. Business: Diagnostic HHSs Biomedical Advanced Research and Development Authority (BARDA) awarded …

    Published on 6/29/2015
  • Veloxis Pharmaceuticals transplant news

    Veloxis Pharmaceuticals A/S (CSE:VELO), Horsholm, Denmark Business: Transplant The U.S. District Court for the District of Columbia ruled that FDA was correct in granting tentative approval of immunosuppressant Envarsus…

    Published on 6/29/2015
  • Adrenergics, CadheRx Therapeutics, Calporta Therapeutics, GlaxoSmithKline cancer, cardiology, endocrine/metabolic news

    Adrenergics Inc., San Diego, Calif. CadheRx Therapeutics Inc., San Diego, Calif. Calporta Therapeutics Inc., San Diego, Calif. GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Cancer, Cardiology, …

    Published on 6/22/2015
  • Amarin, Pharmaceutical Research and Manufacturers of America cardiovascular news

    Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Pharmaceutical Research and Manufacturers of America (PhRMA), Washington, D.C. Business: Cardiovascular PhRMA and a coalition of pharmas criticized FDAs position on drug …

    Published on 6/22/2015
  • Celladon cardiovascular news

    Celladon Corp. (NASDAQ:CLDN), San Diego, Calif. Business: Cardiovascular Celladons board approved a plan to reduce headcount by about 50% to about 17 to save cash and the company hired Wedbush PacGrow Healthcare to seek…

    Published on 6/22/2015
  • OmniSeq, Roswell Park Cancer Institute diagnostic, functional genomics news

    OmniSeq LLC, Buffalo, N.Y. Roswell Park Cancer Institute, Buffalo, N.Y. Business: Diagnostic, Functional genomics OmniSeq began its spinout from Roswell Park and will immediately begin commercializing its OmniSeq …

    Published on 6/22/2015
  • Sequenom, Roche diagnostic news

    Sequenom Inc. (NASDAQ:SQNM), San Diego, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Diagnostic The U.S. Court of Appeals for the Federal Circuit (CAFC) upheld a lower court judgment that U.S. …

    Published on 6/22/2015
  • GlobeImmune infectious news

    GlobeImmune Inc. (NASDAQ:GBIM), Louisville, Colo. Business: Infectious GlobeImmune will cut the majority of its headcount to save cash after GS-4774 missed the primary endpoint in the Phase II GS-US-330-0101 trial to …

    Published on 6/15/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993